FI46846C - Process for the preparation of novel therapeutically active 4-acyloxy-4-allylpiperidine derivatives. - Google Patents

Process for the preparation of novel therapeutically active 4-acyloxy-4-allylpiperidine derivatives.

Info

Publication number
FI46846C
FI46846C FI660066A FI660066A FI46846C FI 46846 C FI46846 C FI 46846C FI 660066 A FI660066 A FI 660066A FI 660066 A FI660066 A FI 660066A FI 46846 C FI46846 C FI 46846C
Authority
FI
Finland
Prior art keywords
allylpiperidine
acyloxy
derivatives
preparation
therapeutically active
Prior art date
Application number
FI660066A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Kuehnis
Denss
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of FI46846C publication Critical patent/FI46846C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
FI660066A 1965-01-15 1966-01-11 Process for the preparation of novel therapeutically active 4-acyloxy-4-allylpiperidine derivatives. FI46846C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH60465A CH460772A (en) 1965-01-15 1965-01-15 Process for the preparation of new piperidine derivatives

Publications (1)

Publication Number Publication Date
FI46846C true FI46846C (en) 1973-07-10

Family

ID=4190825

Family Applications (1)

Application Number Title Priority Date Filing Date
FI660066A FI46846C (en) 1965-01-15 1966-01-11 Process for the preparation of novel therapeutically active 4-acyloxy-4-allylpiperidine derivatives.

Country Status (4)

Country Link
AT (2) AT260244B (en)
CH (1) CH460772A (en)
ES (2) ES321803A1 (en)
FI (1) FI46846C (en)

Also Published As

Publication number Publication date
ES321803A1 (en) 1966-06-16
CH460772A (en) 1968-08-15
ES321804A1 (en) 1967-01-01
AT260244B (en) 1968-02-12
AT260242B (en) 1968-02-12

Similar Documents

Publication Publication Date Title
FI42712C (en) Process for the preparation of therapeutically active biphenylalkane derivatives
DK128318B (en) Analogous process for the preparation of therapeutically active bischromones.
FI49497C (en) Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
FI52335C (en) Process for the preparation of therapeutically active ethylamine derivatives.
FI46373C (en) A process for the preparation of new therapeutically useful derivatives of phenylaminopropane.
FI46069C (en) A process for the preparation of a therapeutically useful 1-R-2-formyl-5-nitroimidazole.
FI46960C (en) Process for the preparation of therapeutically active imidazole derivatives
FI44801C (en) Process for the preparation of new therapeutically active basic ethers.
FI45041C (en) Process for the preparation of therapeutically useful pyrrole derivatives.
FI48083C (en) Process for the preparation of new therapeutically active imidazole derivatives
DK117635B (en) Analogous process for the preparation of therapeutically active 3- (piperazinoalkyl) -pyrazoles.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI50420C (en) Process for the preparation of therapeutically active 4-pyrimidinyl-1,4-dihydropyridine derivatives
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI45045C (en) Process for the preparation of novel therapeutically active 5-nitro-2-furyl-isoxazole derivatives.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI47357C (en) A process for the preparation of therapeutically active 4'-demethyl-epipodophyllotoxin ni-beta-D-glucoside derivatives.
FI46966C (en) Process for the preparation of therapeutically useful 1,3-dihydro-3-hydroxy-1,4-benzodiazepin-2-ones
FI47661C (en) Process for the preparation of therapeutically active benzofuran derivatives.
FI46846C (en) Process for the preparation of novel therapeutically active 4-acyloxy-4-allylpiperidine derivatives.
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI43987C (en) Process for the preparation of pharmacologically active 10-aminoalkyl-dibenz (b, f) azepine derivatives
FI45954C (en) Process for the preparation of therapeutically active benzenesulfonylcuramides.
FI46066C (en) Analogous process for the preparation of therapeutically active N, N-dimethylamino-ethyl-14beta-hydroxy-5beta-pregn-20-ene-21-carboxylates.